GAN-17554-45433
1 vaccination
1 coded response
5 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 190 / PA
- Registered
- 2022-06-04
- Relationship
- Child or adolescent in my care
- Guardian
- JGZ-19595-89271
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-05-24
Dose 1 — Pfizer-BioNTech
-
2022-06-04
Registered in v-safe
- 2022-06-04
- 2022-06-07
- 2022-08-23
- 2022-11-24
-
2023-05-26
Survey response — 12 months, dose 1, dependentMedDRA: Fatigue — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-05-24 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release